by Team Small News | Nov 12, 2025 | Pharma, Sun Pharma
Sun Pharmaceutical Industries, one of India’s largest pharmaceutical companies, has won a significant excise refund battle. The Customs, Excise, and Service Tax Appellate Tribunal (CESTAT) ruled in favor of Sun Pharma, dismissing a revenue demand of Rs 828 crore... by Team Small News | Nov 10, 2025 | Lupin, Pharma
Lupin, a leading pharmaceutical company, has unveiled its ambitious product pipeline and strategic targets, showcasing its commitment to driving growth and innovation in the industry. The company has outlined a robust pipeline of new products and formulations, aimed... by Team Small News | Nov 9, 2025 | Apollo Hospital, Pharma
The healthcare sector is facing a paradox in its approach to protecting life. While its primary principle is “primum non nocere” or “first, do no harm,” the sector itself is contributing to the climate crisis, which is having a devastating...
by Team Small News | Nov 9, 2025 | Pharma, Zydus
Zydus Lifesciences Limited, an Indian pharmaceutical company, has received tentative approval from the United States Food and Drug Administration (USFDA) for its Olaparib Tablets, 100 mg and 150 mg. This medication is used to treat certain types of ovarian, breast,...
by Team Small News | Nov 8, 2025 | Pharma, Piramal Pharma
Motilal Oswal has maintained a “buy” rating on Piramal Pharma despite the company facing near-term headwinds. The brokerage firm reviewed Piramal Pharma’s Q2 results and noted that the company’s performance was impacted by one-time items and...